Steris affirms fiscal 2026 adjusted EPS outlook $9.90-$10.15, consensus $10.04

The company now expects fiscal 2026 revenue from continuing operations to increase 8%-9% compared with prior expectations of 6%-7%. It said, “This change reflects a significant shift in foreign currency outlook, as we now anticipate approximately 200 basis points of favorability to revenue for fiscal 2026, based on forward rates through March 31, 2026. Expectations for constant currency organic revenue growth from continuing operations are unchanged at 6-7%. Adjusted earnings per diluted share from continuing operations is also unchanged in the range of $9.90 to $10.15, as favorable foreign currency changes will be offset by increased tariffs and higher employee healthcare benefit costs. Included in this outlook is the negative impact of tariffs, estimated to reduce pre-tax profit by approximately $45 million, compared with prior expectations of $30 million.”